NRNP 6566

Describe cytochrome p450 system - ANSWER Cytochrome p450 system is a series of enzymes used to metabolize medications Inhibitors - ANSWER block metabolic activity from one or more CYP450 enzymes Inducers - ANSWER increase CYP450 enzyme activity by increasing enzyme synthesis Describe effect on low and high albumin levels on active drug levels especially for drugs that are highly protein bound - ANSWER Albumin is the plasma protein with the greatest capacity for binding drugs. Binding pl...

Week 1 1. Describe the cytochrome P450 system. Describe how inducers and inhibitors affect the cytochrome system and how that affects the half-life of medications. a. Cytochrome p450 system is a series of enzymes used to metabolize medications. b. Drugs that cause CYP450 metabolic drug interactions are referred to as either inhibitors or inducers. Inducers increase CYP450 enzyme activity by increasing enzyme synthesis c. Inhibitors block the metabolic activity of one or more CYP450 enzymes ...

NRNP 6566 Key Concepts Week 1 to 5 spring/NRNP 6566 Key Concepts Week 1 to 5 springNRNP 6566 Key Concepts Week 1 to 5 springNRNP 6566 Key Concepts Week 1 to 5 springNRNP 6566 Key Concepts Week 1 to 5 springNRNP 6566 Key Concepts Week 1 to 5 springNRNP 6566 Key Concepts Week 1 to 5 springNRNP 6566 Key Concepts Week 1 to 5 springNRNP 6566 Key Concepts Week 1 to 5 springNRNP 6566 Key Concepts Week 1 to 5 springNRNP 6566 Key Concepts Week 1 to 5 springNRNP 6566 Key Concepts Week 1 to 5 springNRNP 65...

NRNP 6566 Week 5 Knowledge Check _Spring/NRNP 6566 Week 5 Knowledge Check _SpringNRNP 6566 Week 5 Knowledge Check _SpringNRNP 6566 Week 5 Knowledge Check _SpringNRNP 6566 Week 5 Knowledge Check _SpringNRNP 6566 Week 5 Knowledge Check _SpringNRNP 6566 Week 5 Knowledge Check _SpringNRNP 6566 Week 5 Knowledge Check _SpringNRNP 6566 Week 5 Knowledge Check _SpringNRNP 6566 Week 5 Knowledge Check _SpringNRNP 6566 Week 5 Knowledge Check _SpringNRNP 6566 Week 5 Knowledge Check _SpringNRNP 65...

NRNP 6566 week 1 to 5 Key Concepts. NRNP 6566 Key Concepts Week 1 to 5 Week 1 1. Describe the cytochrome P450 system. Describe how inducers and inhibitors affect the cytochrome system and how that affects the half-life of medications. a. Cytochrome p450 system is a series of enzymes used to metabolize medications. b. Drugs that cause CYP450 metabolic drug interactions are referred to as either inhibitors or inducers. Inducers increase CYP450 enzyme activity by increasing enzyme synth...

NRNP 6566 WEEK 11 FINAL EXAM STUDY GUIDE QUESTIONS WITH CORRECT ANSWERS!!

NRNP 6566 week 6 knowledge check. A 54 year old female has a 30 year pack smoking history. She recently underwent pulmonary function testing which showed moderate obstructive lung disease. What would your treatment plan (including medications) include for this patient? Correct Answer: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2020 suggests that smoking cessation should be immediately pursued if the patient is still smoking. Nicotine replacement (gum, inhal...

NRNP 6566 Week 5 Knowledge Check QUESTION 1 1. A 54-year women is 3 days post abdominal surgery for removal of a cancerous mass in her abdomen. She develops acute shortness of breath associated with tachycardia and hypotension. CT Scan of the chest is positive for multiple small pulmonary embolism. What medication and dosing would you order initially to treat the pulmonary embolism? This patient should be given fondaparinuc (Arixtra) subcutaneously. Dosing is weight- based: 1. 5 mg SQ on...

NRNP 6566 Knowledge Check Week 3 Amiodarone has possible complex interactions with multiple medications. It has an effect on warfarin metabolism. Amiodarone is a potent inhibitor of cytochrome P450 enzymes and inhibition of these enzymes will cause an increased plasma concentration and decreased clearance; thereby increasing the prothrombin time and INR placing the patient at increased risk for bleeding complications. Hence, when given together, warfarin dose should be decreased and frequent...

NRNP 6566 week 11 knowledge check How would you differentiate between diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic syndrome (HHS)? Correct Answer: Both of these conditions will include high levels of blood glucose readings. DKA will exhibit acidosis and urinary ketones while HHS will not. Treatment for each condition is similar with fluid bolus and infusion as well as insulin bolus and infusion. Juan is a 42 year old male with complaints of nausea and vomiting for...